TrialBritish journal of haematology2026
Metabolic heterogeneity-based radiomic model predicts treatment outcomes of primary mediastinal B-cell lymphoma patients in the IELSG37 study.
L Ceriani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.